Multiple executives at Tempus AI Inc. executed significant share sales totaling $20.3 million between Feb. 4-7, according to recent Securities and Exchange Commission filings. The transactions ...

In a regulatory filing, Tempus AI (TEM) disclosed that COO Ryan Fukushima sold 20,000 shares of the company’s stock. The ...

Erik Phelps, the Executive Vice President and Chief Administrative and Legal Officer of Tempus AI , Inc. (NASDAQ:TEM), ...

Chief Operating Officer Ryan Fukushima recently sold a significant portion of his holdings in the company, according to a ...

Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared ...

We recently compiled a list of the 10 Firms Shine Amid Market Slump. In this article, we are going to take a look at where ...

Tempus AI's innovative products are transforming the healthcare industry, with a focus on oncology and large market ...

Let's explore the Tempus AI stock price and whether it is a good company to buy and hold despite its overvaluation.

Key Points About This Article Up about 12%, Tempus AI (NASDAQ: TEM) is rocketing thanks to three key catalysts. One, Tempus AI just acquired Ambry Genetics. Two, Nancy Pelosi and Cathie Wood are ...

In a regulatory filing, Tempus AI (TEM) disclosed that COO Ryan Fukushima sold 20,000 shares of the company’s stock. The stock was sold at an average price of $62.50, for a total value of $1.2M.